
Pharma tariff exemption: Temporary relief, but higher tariffs may be imposed later, warns analyst
US President Donald Trump has exempted pharmaceuticals from his reciprocal tariff plan announced on April 3. While he imposed a 26% tariff on other imports from India, this exemption has provided significant relief to pharmaceutical companies. However, …